India’s drug regulator has given the nod to Eli Lilly’s once-a- week Mounjaro (tirzepatide) injection in the KwikPen format, ...

A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and ...

A new potential drug treatment for people with type 2 diabetes and obesity lowers blood sugar and increases fat burning.

Lower blood sugar and increased fat burning—without negatively affecting appetite or muscle mass. These are some of the most ...

A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and ...

A GLP-1 medication used to treat type 2 diabetes and obesity may help cut a person's monthly migraine days by about half, a ...

A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...

A recent study found that older adults with diabetes who use a GLP-1 drug have double the risk of developing wet age-related ...

Diabetes is a chronic metabolic disorder characterised by persistently high blood sugar levels (hyperglycaemia) caused by ...

A drug commonly prescribed to manage type 2 diabetes may also reduce the risk of prostate cancer recurrence in men with diabetes, according to a new study published in Molecular Cancer.The research, ...

The extensive research analyzed data from over 92,000 individuals aged 50 and older who had been diagnosed with type 2 diabetes. Focusing on two classes of diabetes drugs—GLP-1 receptor agonists ...